Side chain oxidized oxysterols in cerebrospinal fluid and the integrity of blood-brain and blood-cerebrospinal fluid barriers - PubMed (original) (raw)
Side chain oxidized oxysterols in cerebrospinal fluid and the integrity of blood-brain and blood-cerebrospinal fluid barriers
Valerio Leoni et al. J Lipid Res. 2003 Apr.
Free article
Abstract
The side chain oxidized oxysterol 24S-hydroxycholesterol (24-OH-chol) is formed almost exclusively in the brain, and there is a continuous passage of this oxysterol through the circulation to the liver. 27-Hydroxycholesterol (27-OH-chol) is produced in most organs and is also taken up by the liver. The 27-OH-chol-24-OH-chol ratio is about 0.1 in the brain and about 2 in the circulation. This ratio was found to be about 0.4 in cerebrospinal fluid (CSF) of asymptomatic patients, consistent with a major contribution from the circulation in the case of 27-OH-chol. In accordance with this, we demonstrated a significant flux of deuterium labeled 27-OH-chol from plasma to the CSF in a healthy volunteer. Patients with a defective blood-brain barrier were found to have markedly increased absolute levels (up to 10-fold) of both 27-OH-chol and 24-OH-chol in CSF, with a ratio between the two sterols reaching up to 2. There was a significant positive correlation between the levels of both oxysterols in CSF and the albuminCSF-albuminplasma ratio. The 27-OH-cholCSF-24-OH-cholCSF ratio was found to be about normal in patients with active multiple sclerosis and significantly increased in patients with meningitis, polyneuropathy, or hemorrhages. Results are discussed in relation to the possible use of 24-OH-cholCSF as a surrogate marker of central nervous system demyelination and/or neuronal death.
Similar articles
- On the fluxes of side-chain oxidized oxysterols across blood-brain and blood-CSF barriers and origin of these steroids in CSF (Review).
Björkhem I, Leoni V, Svenningsson P. Björkhem I, et al. J Steroid Biochem Mol Biol. 2019 Apr;188:86-89. doi: 10.1016/j.jsbmb.2018.12.009. Epub 2018 Dec 23. J Steroid Biochem Mol Biol. 2019. PMID: 30586624 Review. - Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation.
Lütjohann D, Breuer O, Ahlborg G, Nennesmo I, Sidén A, Diczfalusy U, Björkhem I. Lütjohann D, et al. Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9799-804. doi: 10.1073/pnas.93.18.9799. Proc Natl Acad Sci U S A. 1996. PMID: 8790411 Free PMC article. - Changes in human plasma levels of the brain specific oxysterol 24S-hydroxycholesterol during progression of multiple sclerosis.
Leoni V, Masterman T, Diczfalusy U, De Luca G, Hillert J, Björkhem I. Leoni V, et al. Neurosci Lett. 2002 Oct 18;331(3):163-6. doi: 10.1016/s0304-3940(02)00887-x. Neurosci Lett. 2002. PMID: 12383922 - Oxysterols and Parkinson's disease: evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease.
Björkhem I, Lövgren-Sandblom A, Leoni V, Meaney S, Brodin L, Salveson L, Winge K, Pålhagen S, Svenningsson P. Björkhem I, et al. Neurosci Lett. 2013 Oct 25;555:102-5. doi: 10.1016/j.neulet.2013.09.003. Epub 2013 Sep 10. Neurosci Lett. 2013. PMID: 24035896 - Oxysterols as markers of neurological disease--a review.
Leoni V. Leoni V. Scand J Clin Lab Invest. 2009;69(1):22-5. doi: 10.1080/00365510802651858. Scand J Clin Lab Invest. 2009. PMID: 19199127 Review.
Cited by
- Longitudinal Data in Patients with Niemann-Pick Type C Disease Under Combined High Intrathecal and Low Intravenous Dose of 2-hydroxylpropyl-β-cyclodextrin.
Bountouvi E, Giorgi M, Papadopoulou A, Blennow K, Björkhem I, Tsirouda M, Kanellakis S, Fryganas A, Spanou M, Georgaki I, Asprogeraka S, Dinopoulos A. Bountouvi E, et al. Innov Clin Neurosci. 2021 Jan 1;18(1-3):11-16. eCollection 2021 Jan-Mar. Innov Clin Neurosci. 2021. PMID: 34150357 Free PMC article. - 24-Hydroxycholesterol Induces Tau Proteasome-Dependent Degradation via the SIRT1/PGC1α/Nrf2 Pathway: A Potential Mechanism to Counteract Alzheimer's Disease.
Testa G, Giannelli S, Sottero B, Staurenghi E, Giaccone G, Caroppo P, Gamba P, Leonarduzzi G. Testa G, et al. Antioxidants (Basel). 2023 Mar 3;12(3):631. doi: 10.3390/antiox12030631. Antioxidants (Basel). 2023. PMID: 36978879 Free PMC article. - The Controversial Role of 24-S-Hydroxycholesterol in Alzheimer's Disease.
Gamba P, Giannelli S, Staurenghi E, Testa G, Sottero B, Biasi F, Poli G, Leonarduzzi G. Gamba P, et al. Antioxidants (Basel). 2021 May 7;10(5):740. doi: 10.3390/antiox10050740. Antioxidants (Basel). 2021. PMID: 34067119 Free PMC article. Review. - Biomarkers of Alzheimer disease in plasma.
Irizarry MC. Irizarry MC. NeuroRx. 2004 Apr;1(2):226-34. doi: 10.1602/neurorx.1.2.226. NeuroRx. 2004. PMID: 15717023 Free PMC article. Review. - Cholesterol Dysmetabolism in Alzheimer's Disease: A Starring Role for Astrocytes?
Staurenghi E, Giannelli S, Testa G, Sottero B, Leonarduzzi G, Gamba P. Staurenghi E, et al. Antioxidants (Basel). 2021 Nov 26;10(12):1890. doi: 10.3390/antiox10121890. Antioxidants (Basel). 2021. PMID: 34943002 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources